A randomized Phase II study comparing SOX+B-mab with SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with KRAS wild type.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Nov 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary) ; Bevacizumab; Cetuximab
- Indications Colorectal cancer
- Focus Therapeutic Use
- 14 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 14 Nov 2011 New trial record